A clinical research study for adults of African or Caribbean descent.

This clinical research study is investigating if focal segmental glomerulosclerosis (FSGS) is genetic in some patients and is caused by a variation in the apolipoprotein L1 (APOL1) gene. If you have been diagnosed with FSGS, you may be able to take part.

Find a Participating Site

About the study.

Genetic testing can be done to see if you were born with the variation in your APOL1 gene that causes genetic FSGS. The study will require a blood test to determine if you have this gene variation. The results of this genetic test may qualify you for a future clinical research study for adults with FSGS.

The test used to determine if you have an APOL1 gene variation is not FDA approved, which means that it is not available outside of a research study and is not intended to drive decisions about your medical care. As with any genetic test, there is a risk of inaccurate results. Vertex is taking efforts to reduce this risk by testing your blood sample under industry standard processes and guidelines. If you would like more information about this genetic test, please ask your study doctor.

We are currently enrolling adults 18 years or older who have been diagnosed with biopsy-confirmed FSGS to take part in this clinical research study. It may be appropriate for those who meet the following criteria:

  • Male or female of African or Caribbean descent
  • Diagnosed with FSGS via a kidney biopsy
  • Willing and able to comply with the testing requirements

Those who qualify will receive this testing at no cost. If you qualify, you may be compensated for your study-related time and travel. You may also be eligible for travel assistance.

Find a participating site.

Enter your zip code below or click on the map to find the participating research site(s) nearest you.

Active site locations Potential site locations

About FSGS.

FSGS is a disease that scars the kidney, often leading to kidney failure. FSGS can have many different causes, including infection, disease, some medications, and genetics. If you are of African or Caribbean descent, it is possible that your condition is genetic and caused by a variation in the apolipoprotein L1 (APOL1) gene, which resides on chromosome 22. APOL1 has also been shown to contribute to FSGS disease progression.

What you should know about clinical research studies.

What is a clinical research study?

Clinical research studies, also called clinical trials, are carefully designed research studies in people to determine if an investigational medicine is safe and effective. We encourage patients to speak first with their doctor about their eligibility to enroll in a clinical research study. New medicines are made possible by the volunteers who participate in clinical research studies.

In most countries, the regulatory health authority, such as the Food and Drug Administration (FDA) in the United States, requires that several phases of clinical research be performed to better understand the safety and effectiveness of new investigational drugs and certain medical devices.

Clinical research studies must be approved by an institutional review board (IRB) or ethics committee (EC). An IRB/EC is a group that is responsible for helping to protect the rights and welfare of study participants.

How long will study participation last?

Participation in this study consists of one visit for the blood test. This test may qualify you for a future clinical research study for adults with FSGS.

Thank you for your consideration of this important study.

Find a Participating Site